AT1 3.33% 3.1¢ atomo diagnostics limited

Media Update, page-6

  1. 1,563 Posts.
    lightbulb Created with Sketch. 141
    Access Bio,'Surge' in US Approval of Corona 19 Antigen Diagnosis Kit

    Han Soo-yeon

    Input 2020.10.12 09:19

    Revision 2020.10.12 09:19

    comment 0dog

    Accessbio surged as it obtained emergency use approval (EUA) from the US Food and Drug Administration (FDA) for a rapid diagnosis kit for the novel coronavirus infection (Corona 19) antigen.

    As of 9:15 am on the 12th, Access Bio in the KOSDAQ market is trading at 34,000 won, up 25.69% (6,950 won) compared to the previous trading day.

    On the 10th, Accessbio announced on the 10th that its Corona 19 antigen rapid diagnosis kit'CareStart™ COVID-19 Antigen' has obtained emergency approval from the US FDA. This kit is a product that can quickly diagnose the presence of corona infection within 10 to 15 minutes by collecting a patient's sample from the nasopharynx and immunochromatography.


    This new looks very positive to me : ) . just waiting on the approval of CareStart COVID-19 IgM/IgG. lol
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
3.1¢
Change
0.001(3.33%)
Mkt cap ! $19.81M
Open High Low Value Volume
3.0¢ 3.1¢ 2.9¢ $4.745K 159.6K

Buyers (Bids)

No. Vol. Price($)
1 123968 3.0¢
 

Sellers (Offers)

Price($) Vol. No.
3.1¢ 53324 2
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
3.1¢
  Change
0.001 ( 3.33 %)
Open High Low Volume
3.0¢ 3.1¢ 2.9¢ 32795
Last updated 15.59pm 03/05/2024 ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.